Contact Us Now

For a free, confidential

Doribax Legal Information Center

The U.S. Food and Drug Administration (FDA) is warning the public that the antibiotic doripenem—sold under the brand name Doribax—might increase the risk of death compared to other, similar drugs.

What Is Doribax and What Is It Prescribed For?

Doribax is a member of the carbapenem class of antibiotics. It interferes with certain bacterias’ cell wall formation processes. The Japanese pharmaceutical company, Shionogi, Inc., makes Doribax. The FDA approved it in October 2007 in the form of an intravenous injection. It can be used to treat complicated intra-abdominal infections (like pneumonia) and complicated urinary tract infections, including pyelonephritis (kidney inflammation).

Doribax Risks

According to the FDA’s drug safety communication, which was issued on March 6, 2013, a clinical trial showed that Doribax carried an increased likelihood of death and lower cure rates compared to other drugs when used in patients on ventilators who develop pneumonia. The three-year clinical trial was stopped in 2011 when researchers determined that two other antibiotics, imipenem and cilastatin, were safer and more effective. The agency approved changes to Doribax’s label explaining these risks and advised that Doribax is not approved to treat pneumonia to patients on ventilators. It is still considered safe for its on-label treatments, though.

The label-change also included a new entry in the “warnings and precautions” section advising that patients with preexisting central nervous system disorders were at a higher risk of developing seizures than previously known.

How Can a Lawsuit Help Me?

If you or a loved one took Doribax while on a ventilator, and you believe it caused a deadly injury or seizure, then a lawsuit can help you hold the manufacturer accountable. The amount of compensation from a Doribax lawsuit can include damages for full medical expenses, lost earnings, pain and suffering, and other damages. For a free, confidential legal consultation with a lawyer from the Rottenstein Law Group, click on this link or call 1 (888) 976-8529. RLG will keep you up to date on any Doribax class action lawsuits, additional FDA Doribax warnings, and Doribax FDA recall announcements. If you or a loved one has taken Doribax, and you believe it caused an injury, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.



RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.